Assertio Holdings | DEPO - Sales Revenues

Stock Price
19.39
Daily Change
-0.14 -0.72%
Monthly
64.74%
Yearly
86.88%
Q1 Forecast
18.01

Assertio Holdings reported $29.2M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
ANI Pharmaceuticals USD 247.06M 19.25M Dec/2025
Assertio Holdings USD 29.2M 1.92M Sep/2024
Aurora Cannabis CAD 94.19M 3.82M Dec/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Daiichi Sankyo JPY 558.11B 57.35B Dec/2025
Ironwood Pharmaceuticals USD 47.71M 74.35M Dec/2025
J&J USD 24.6B 610M Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Merck USD 16.4B 880M Dec/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Pfizer USD 17.58B 880M Dec/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025